Pre-ASNO NNI-Duke Neuro-Oncology Symposium

Venue: Academia (SGH campus), Singapore
Audience: Healthcare Professionals
Cost:

The National Neuroscience Institute (NNI) is a clinical institution under SingHealth, a part of the SingHealth Duke-NUS Academic Medical Centre. The NNI Neuro-Oncology program, which began over 15 years ago, has evolved into a translational program focusing on precision medicine for Glioblastoma. This year, in collaboration with Duke University, we are privileged to host colleagues from the Preston Robert Tisch Brain Tumor Centre. Together with our local team and academic institutions, we will present a comprehensive neuro-oncology symposium, highlighting biobanking strategies, patient stratification approaches, biomedical engineering applications, and avenues to translate bench findings in brain tumor immunology to clinical practice.

Registration is free! Click here or scan QR code to register now.

Acknowledgement

This research is supported by the National Research Foundation Singapore under its Open Fund - Large Collaborative Grant (MOH-000541) and administered by the Singapore Ministry of Health's National Medical Research Council.

Supported By	Sponsor

Programme

Symposium Chairperson: Assoc Prof Christopher Ang

Time (SGT)	Topic	Speakers
0830 – 0900	Registration
0900 – 0905	Opening Ceremony	Guest-of-Honour: Prof Ng Wai Hoe Group Chief Executive Officer, SingHealth
Session 1
0905 – 0935	The NNI Glioblastoma Biobanking and Precision Medicine Program	Assoc Prof Christopher Ang National Neuroscience Institute
0935 – 1005	Intraoperative Molecular Genotyping for Brain Tumours	Prof Hai Yan Institute of Molecular and Cell Biology, A*STAR
1005 – 1035	A Paradigm Shift in the Approach to Diagnose and Treat Glioblastoma Tumours	Assoc Prof Carol Tang Cancer & Stem Cell Biology Program, Duke-NUS Medical School SG Enable
1035 – 1105	Tea Break
Session 2
1105 – 1135	Surgical Management of Glioblastoma in the Era of Precision Medicine	Prof Peter E. Fecci Duke University School of Medicine, USA
1135 – 1205	Development of Preclinical Models of Brain Tumours	Dr Wan Yee Teo Cancer & Stem Cell Biology Program, Duke-NUS Medical School KK Women’s & Children’s Hospital
1205 – 1235	The Spatial Characterization of High-Grade Glioma	Prof Simon G. Gregory Duke Molecular Physiology Institute, USA
1235 – 1335	Lunch
Session 3
1335 – 1405	Mechanisms of Systemic Immunosuppression in GBM	Dr Katayoun Ayasoufi Duke University, USA
1405 – 1435	Immunotherapy in Glioblastoma: Identifying and Exploiting Innate-Based Therapeutic Vulnerabilities	Prof David M. Ashley Duke University School of Medicine, USA
1435 – 1505	DIPG Differentiation Enables Tumour-to-Midbrain Aggression	Prof Qi-Jing Li Institute of Molecular and Cell Biology, A*STAR
1505 – 1535	Tea Break
Session 4
1535 – 1605	Integrated Nanosensor Technologies for Molecular Analyses of Circulating Biomarkers	Assoc Prof Huilin Shao National University of Singapore
1605 – 1635	Integrating Novel OMICS Technologies into Prospective Clinical Trial	Prof Mustafa Khasraw Duke Cancer Institute, USA
Closing Address
1635 - 1640	The Road Ahead	Assoc Prof Christopher Ang National Neuroscience Institute
End of Symposium